Ferozsons Laboratories Limited (PSX: FEROZ)

Market Cap	14.51B
Revenue (ttm)	15.96B
Net Income (ttm)	640.44M
Shares Out	43.47M
EPS (ttm)	14.73
PE Ratio	22.65
Forward PE	n/a
Dividend	3.00 (0.90%)
Ex-Dividend Date	Oct 18, 2024

Volume	63,712
Average Volume	97,791
Open	340.90
Previous Close	339.38
Day's Range	334.00 - 344.97
52-Week Range	197.00 - 393.00
Beta	0.59
RSI	50.32
Earnings Date	Feb 17, 2025

About Ferozsons Laboratories

Ferozsons Laboratories Limited, together with its subsidiaries, engages in the importing, manufacturing, and sale of pharmaceutical products and medical devices in Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, Cambodia, and internationally. The company offers products in various therapeutic areas of anti-fungal, anti-viral, antibiotics, cardiometabolic, cough, dermatology, diabetes, gastrointestinal and liver, oncology, orthopedic, and urology and nephrology areas. It also provides medical devices in t...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1954
• Employees: 1,896
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: FEROZ

Financial Performance

In 2024, Ferozsons Laboratories's revenue was 15.85 billion, an increase of 38.38% compared to the previous year's 11.46 billion. Earnings were 683.15 million, an increase of 151.83%.